First Albany Starts MTS Medication Technologies (MPP) at Strong Buy
More News related to MPP
- Broadpoint Downgrades MTS Medication (MPP) to Neutral
- First Albany Starts MTS Medication Technologies (MPP) at Strong Buy
- MTS Medication Tech (MPP) Misses Q4 EPS by 1c, Guides for FY08
- Medication Technologies (MPP) Appoints Michael Conroy as CFO
More News related to New Coverage
- Janney Montgomery Scott Initiates Coverage on Papa John's International (PZZA) with a Neutral
- Feltl & Co. Initiates Coverage on ActivIdentity (ACTI) with a Buy
- Oscar Gruss Initiates Coverage Airgas (ARG) with a Buy
- Sidoti & Co Initiates Coverage on Solutia (SOA) with a Buy
- RBC Capital Initiates Coverage on Questar (STR) with a Sector Perform
First Albany initiates coverage on MTS Medication Technologies (AMEX: MPP) with a Strong Buy rating $16 price target.
Related Categories
New CoverageStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
